Can a phone call keep heart failure patients out of the hospital?
NCT ID NCT07100561
First seen Sep 10, 2026 · Last updated Sep 11, 2026 · Updated 1 time
Summary
Heart failure is the leading cause of heart-related hospital admissions in Ghana, and many patients return to hospital soon after discharge. This pilot trial tests whether extra counselling from a study doctor, pharmacist, or nurse, plus weekly phone follow-up calls for the first 30 days and then every four weeks until day 90, can lower the number of heart failure readmissions at 30 and 90 days. Researchers will enroll 220 adults with heart failure at Komfo Anokye Teaching Hospital and compare those who receive the extra support with those who receive standard care.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Extra discharge counselling from a study doctor, pharmacist, or trained nurse plus weekly phone follow-up calls
- What this could lead to
- If it works, this could give hospitals a low-cost way to keep heart failure patients out of the hospital after discharge.
- What could go wrong
- This is a small pilot trial at one hospital in Ghana, so the results may not apply elsewhere. Phone follow-up depends on patients having working phones and may not suit everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 220 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jul 2025
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * · Adults Aged 18 years and above * Diagnosed with heart failure * NYHA Class II-IV * Informed consent Exclusion Criteria: * · NHYA class I * Patients who do not have access to a mobile phone
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Heart failure are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Komfo Anokye Teaching Hospital
RECRUITINGKumasi, Ashanti Region, Ghana
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which SGLT2 inhibitor wins? trial pits empagliflozin against dapagliflozin
- Can daily mindful breathing ease heart failure symptoms?
- Can a smartphone app keep heart failure patients out of the hospital?
- Can better training get doctors to talk about what matters most to dying veterans?
- Can AI read heart ultrasounds as well as trained sonographers?
- Can modern heart failure drugs reverse damage in three months?